STAT1-dependent and STAT1-independent gene expression in murine immune cells following stimulation with interferon-alpha

Cancer Immunology, Immunotherapy

Volumn 56, Issue 11, 2007, Pages 1845-1852

  Zimmerer, Jason M ^a   Lesinski, Gregory B ^a   Radmacher, Michael D ^a   Ruppert, Amy ^a   Carson III, William E ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Immune cells; Interferon alpha; Oligonucleotide microarray analysis; STAT1

Indexed keywords

ALPHA INTERFERON; BINDING PROTEIN; CD86 ANTIGEN; DAXX PROTEIN; GRANZYME B; INTERFERON REGULATORY FACTOR 7; LYMPHOCYTE ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES; STAT1 PROTEIN; TAP BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE REPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPLEEN CELL; UPREGULATION; WILD TYPE;

ANIMALS; ANTINEOPLASTIC AGENTS; GENE EXPRESSION REGULATION; INTERFERON-ALPHA; MICE; MICE, INBRED C57BL; MICROARRAY ANALYSIS; SIGNAL TRANSDUCTION; SPLEEN; STAT1 TRANSCRIPTION FACTOR; UP-REGULATION;

EID: 34548167742     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-007-0329-9     Document Type: Article

References (37)

1. Badgwell B, Lesinski GB, Magro C, Abood G, Skaf A, Carson W III (2004) The antitumor effects of interferon-alpha are maintained in mice challenged with a STAT1-deficient murine melanoma cell line. J Surg Res 116:129-136
2. Bauer JA, Morrison BH, Grane RW, Jacobs BS, Borden EC, Lindner DJ (2003) IFN-alpha2b and thalidomide synergistically inhibit tumor-induced angiogenesis. J Interferon Cytokine Res 23:3-10
3. Belardelli F, Ferrantini M, Proietti E, Kirkwood JM (2002) Interferon-alpha in tumor immunity and immunotherapy. Cytokine Growth Factor Rev 13:119-134
4. Belardelli F, Gresser I, Maury C, Maunoury MT (1982) Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. I. Int J Cancer 30:813-820
5. Belardelli F, Gresser I, Maury C, Maunoury MT (1982) Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. II. Role of host mechanisms. Int J Cancer 30:821-825
6. Biron CA (2001) Interferons alpha and beta as immune regulators-a new look. Immunity 14:661-664
7. Brassard DL, Grace MJ, Bordens RW (2002) Interferon-alpha as an immunotherapeutic protein. J Leukoc Biol 71:565-581
8. Carr DJ, Chodosh J, Ash J, Lane TE (2003) Effect of anti-CXCL10 monoclonal antibody on herpes simplex virus type 1 keratitis and retinal infection. J Virol 77:10037-10046
9. Darnell JE Jr, Kerr IM, Stark GR (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421
10. Durbin JE, Hackenmiller R, Simon MC, Levy DE (1996) Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84:443-450
11. Fallarino F, Gajewski TF (1999) Cutting edge: differentiation of antitumor CTL in vivo requires host expression of Stat1. J Immunol 163:4109-4113
12. Frey AB (2006) Myeloid suppressor cells regulate the adaptive immune response to cancer. J Clin Invest 116:2587-2590
13. Fuse S, Obar JJ, Bellfy S, Leung EK, Zhang W, Usherwood EJ (2006) CD80 and CD86 control antiviral CD8+ T-cell function and immune surveillance of murine gammaherpesvirus 68. J Virol 80:9159-9170
14. Garbe C, Krasagakis K, Zouboulis CC, Schroder K, Kruger S, Stadler R, Orfanos CE (1990) Antitumor activities of interferon alpha, beta, and gamma and their combinations on human melanoma cells in vitro: changes of proliferation, melanin synthesis, and immunophenotype. J Invest Dermatol 95:231S-237S
15. Gil MP, Bohn E, O'Guin AK, Ramana CV, Levine B, Stark GR, Virgin HW, Schreiber RD (2001) Biologic consequences of Stat1-independent IFN signaling. Proc Natl Acad Sci USA 98:6680-6685
16. Grant EP, Michalek MT, Goldberg AL, Rock KL (1995) Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation. J Immunol 155:3750-3758
17. Gresser I, Kaido T, Maury C, Woodrow D, Moss J, Belardelli F (1994) Interaction of IFN alpha/beta with host cells essential to the early inhibition of Friend erythroleukemia visceral metastases in mice. Int J Cancer 57:604-611
18. Gresser I, Maury C, Carnaud C, De Maeyer E, Maunoury MT, Belardelli F (1990) Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend erythroleukemia cells. VIII. Role of the immune system in the inhibition of visceral metastases. Int J Cancer 46:468-474
19. Haque SJ, Williams BR (1998) Signal transduction in the interferon system. Semin Oncol 25:14-22
20. Imanishi T, Kamigaki T, Nakamura T, Hayashi S, Yasuda T, Kawasaki K, Takase S, Ajiki T, Kuroda Y (2006) Correlation between expression of major histocompatibility complex class I and that of antigen presenting machineries in carcinoma cell lines of the pancreas, biliary tract and colon. Kobe J Med Sci 52:85-95
21. Jaakkola I, Merinen M, Jalkanen S, Hanninen A (2003) Ly6C induces clustering of LFA-1 (CD11a/CD18) and is involved in subtype-specific adhesion of CD8 T cells. J Immunol 170:1283-1290
22. Koon H, Atkins M (2006) Autoimmunity and immunotherapy for cancer. N Engl J Med 354:758-760
23. Lesinski GB, Anghelina M, Zimmerer J, Bakalakos T, Badgwell B, Parihar R, Hu Y, Becknell B, Abood G, Chaudhury AR, Magro C, Durbin J, Carson WE III (2003) The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse. J Clin Invest 112:170-180
24. Lesinski GB, Kondadasula SV, Crespin T, Shen L, Kendra K, Walker M, Carson WE III (2004) Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy. J Natl Cancer Inst 96:1331-1342
25. Levy D, Reich N, Kessler D, Pine R, Darnell JE Jr (1988) Transcriptional regulation of interferon-stimulated genes: a DNA response element and induced proteins that recognize it. Cold Spring Harb Symp Quant Biol 53(Pt 2):799-802
26. Li C, Wong WH (2003) The analysis of gene expression data: methods and software. DNA-Chip Analyzer (dChip)
27. Lin MY, Zal T, Ch'en IL, Gascoigne NR, Hedrick SM (2005) A pivotal role for the multifunctional calcium/calmodulin-dependent protein kinase II in T cells: from activation to unresponsiveness. J Immunol 174:5583-5592
28. Maellaro E, Pacenti L, Del Bello B, Valentini MA, Mangiavacchi P, De Felice C, Rubegni P, Luzi P, Miracco C (2003) Different effects of interferon-alpha on melanoma cell lines: a study on telomerase reverse transcriptase, telomerase activity and apoptosis. Br J Dermatol 148:1115-1124
29. Moschella F, Bisikirska B, Maffei A, Papadopoulos KP, Skerrett D, Liu Z, Hesdorffer CS, Harris PE (2003) Gene expression profiling and functional activity of human dendritic cells induced with IFN-alpha-2b: implications for cancer immunotherapy. Clin Cancer Res 9:2022-2031
30. Moschos SJ, Edington HD, Land SR, Rao UN, Jukic D, Shipe-Spotloe J, Kirkwood JM (2006) Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responses. J Clin Oncol 24:3164-3171
31. Mullbacher A, Waring P, Tha Hla R, Tran T, Chin S, Stehle T, Museteanu C, Simon MM (1999) Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes. Proc Natl Acad Sci USA 96:13950-13955
32. Parronchi P, Mohapatra S, Sampognaro S, Giannarini L, Wahn U, Chong P, Maggi E, Renz H, Romagnani S (1996) Effects of interferon-alpha on cytokine profile, T cell receptor repertoire and peptide reactivity of human allergen-specific T cells. Eur J Immunol 26:697-703
33. Ramana CV, Gil MP, Han Y, Ransohoff RM, Schreiber RD, Stark GR (2001) Stat1-independent regulation of gene expression in response to IFN-gamma. Proc Natl Acad Sci USA 98:6674-6679
34. Rizvi SM, Raghavan M (2006) Direct peptide-regulatable interactions between MHC class I molecules and tapasin. Proc Natl Acad Sci USA 103:18220-18225
35. Saborit-Villarroya I, Del Valle JM, Romero X, Esplugues E, Lauzurica P, Engel P, Martin M (2005) The adaptor protein 3BP2 binds human CD244 and links this receptor to Vav signaling, ERK activation, and NK cell killing. J Immunol 175:4226-4235
36. Zimmerer JM, Lesinski GB, Kondadasula SV, Karpa VI, Lehman A, Raychaudhury A, Becknell B, Carson WE III (2007) IFN-{alpha}-Induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins. J Immunol 178:4832-4845
37. Zimmerer JM, Lesinski GB, Kornacker K, Shen L, Liyanarachichi S, Durbin J, Kendra K, Walker M, Carson WE (2003) Gene expression profiling of the response to interferon-alpha immunotherapy. American Association for Cancer Research Annual Meeting, Orlando, FL [Abstract no. 4679]